By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein structure analysis firm Proteros today announced a deal with the University of Cincinnati, Drug Discovery Center to provide biotechnology and drug firms access to UC DDC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

Proteros, based in Martinsried, Germany, will serve as a single point of contact and be responsible for all client interactions and project management.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.